1. Repositório Institucional da UFMG
  2. Publicações Científicas e Culturais
  3. Artigo de Periódico
Please use this identifier to cite or link to this item: http://hdl.handle.net/1843/55209
Full metadata record
DC FieldValueLanguage
dc.creatorJefferson Beckerpt_BR
dc.creatorLis Campos Ferreirapt_BR
dc.creatorAlfredo Damascenopt_BR
dc.creatorDenis Bernardi Bichuettipt_BR
dc.creatorPaulo Pereira Christopt_BR
dc.creatorDagoberto Callegaropt_BR
dc.creatorMarco Aurélio Lana Peixotopt_BR
dc.creatorNise Alessandra de Carvalho Sousapt_BR
dc.creatorSérgio Monteiro de Almeidapt_BR
dc.creatorTarso Adonipt_BR
dc.creatorJuliana Machado Santiago dos Santos Amaralpt_BR
dc.creatorThiago de Faria Junqueirapt_BR
dc.creatorSamira Luisa Apóstolos Pereirapt_BR
dc.creatorAna Beatriz Ayroza Galvão Ribeiro Gomespt_BR
dc.creatorMilena Sales Pitombeirapt_BR
dc.creatorRenata Barbosa Paolilopt_BR
dc.creatorAnderson Kuntz Grzesiukpt_BR
dc.creatorAna Claudia Piccolopt_BR
dc.creatorJosé Arthur Costa D´Almeidapt_BR
dc.creatorAntônio Pereira Gomes Netopt_BR
dc.creatorAugusto César Penalva de Oliveirapt_BR
dc.creatorBianca Etelvina Santos de Oliveirapt_BR
dc.creatorCarlos Bernardo Tauilpt_BR
dc.creatorClaudia Cristina Ferreira Vasconcelospt_BR
dc.creatorDamacio Ramón Kaimen Macielpt_BR
dc.creatorDaniel Lima Varelapt_BR
dc.creatorDenise Sisterolli Dinizpt_BR
dc.creatorEnedina Maria Lobato de Oliveirapt_BR
dc.creatorFabiola Rachid Malfetanopt_BR
dc.creatorFernando Elias Borgespt_BR
dc.creatorFernando Faria Andrade Figueirapt_BR
dc.creatorFrancisco de Assis Aquino Gondimpt_BR
dc.creatorGiordani Rodrigues dos Passospt_BR
dc.creatorGuilherme Diogo Silvapt_BR
dc.creatorGuilherme Sciascia do Olivalpt_BR
dc.creatorGutemberg Augusto Cruz dos Santospt_BR
dc.creatorHeloisa Helena Ruoccopt_BR
dc.creatorHenry Koiti Satopt_BR
dc.creatorHerval Ribeiro Soares Netopt_BR
dc.creatorLeandro Cortoni Caliapt_BR
dc.creatorMarcus Vinícius Magno Gonçalvespt_BR
dc.creatorMaria Cecilia Aragón de Vecinopt_BR
dc.creatorMaria Lucia Vellutini Pimentelpt_BR
dc.creatorMarlise de Castro Ribeiropt_BR
dc.creatorMateus Boaventura de Oliveirapt_BR
dc.creatorMônica Koncke Fiuza Parolinpt_BR
dc.creatorRenata Brant de Souza Melopt_BR
dc.creatorRobson Lázaropt_BR
dc.creatorRodrigo Barbosa Thomazpt_BR
dc.creatorRodrigo Gonçalves Kleinpaul Vieirapt_BR
dc.creatorRonaldo Maciel Diaspt_BR
dc.creatorSidney Gomespt_BR
dc.creatorSimone Abrante Lucattopt_BR
dc.creatorSoniza Vieira Alves Leonpt_BR
dc.creatorThiago Fukudapt_BR
dc.creatorTaysa Alexandrino Gonsalves Jubé Ribeiropt_BR
dc.creatorThereza Cristina D’ávila Wincklerpt_BR
dc.creatorYara Dadalti Fragosopt_BR
dc.creatorOsvaldo José Moreira do Nascimentopt_BR
dc.creatorMaria Lucia Brito Ferreirapt_BR
dc.creatorMaria Fernanda Mendespt_BR
dc.creatorDoralina Guimarães Brum Souzapt_BR
dc.creatorFelipe von Glehn da Silvapt_BR
dc.date.accessioned2023-06-21T19:57:13Z-
dc.date.available2023-06-21T19:57:13Z-
dc.date.issued2021-11-
dc.citation.volume79pt_BR
dc.citation.issue11pt_BR
dc.citation.spage1049pt_BR
dc.citation.epage1061pt_BR
dc.identifier.doihttps://doi.org/10.1590/0004-282X-ANP-2021-0162pt_BR
dc.identifier.issn1678-4227pt_BR
dc.identifier.urihttp://hdl.handle.net/1843/55209-
dc.description.abstractO DC de Neuroimunologia da ABN e o BCTRIMS trazem, nesse documento, as recomendações sobre vacinação da população com doenças desmielinizantes do sistema nervoso central (SNC) contra infecções em geral e contra o coronavírus da síndrome respiratória aguda grave 2 (SARS-CoV-2), causador da COVID-19. Destaca-se a gravidade do atual momento frente ao avanço da COVID-19 em nosso País, o que torna mais evidente e importante a criação de guia de referência para orientação aos médicos, pacientes e autoridades de saúde pública quanto à vacinação, meio efetivo e seguro no controle de determinadas doenças infecciosa. O DCNI/ABN e o BCTRIMS recomendam que os pacientes com doenças desmielinizantes do SNC (ex., EM e NMOSD) sejam constantemente monitorados, quanto a atualização do seu calendário vacinal, especialmente, no início ou antes da mudança do tratamento com uma droga modificadora de doença (DMD). É importante também salientar que as vacinas são seguras e os médicos devem estimular o seu uso em todos os pacientes. Evidentemente, deve ser dada especial atenção às vacinas com vírus vivos atenuados. Por fim, é importante que os médicos verifiquem qual DMD o paciente está em uso e quando foi feita a sua última dose, pois cada fármaco pode interagir de forma diferente com a indução da resposta imune.pt_BR
dc.description.resumoThe Scientific Department of Neuroimmunology of the Brazilian Academy of Neurology (DCNI/ABN) and Brazilian Committee for Treatment and Research in Multiple Sclerosis and Neuroimmunological Diseases (BCTRIMS) provide recommendations in this document for vaccination of the population with demyelinating diseases of the central nervous system (CNS) against infections in general and against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19. We emphasize the seriousness of the current situation in view of the spread of COVID-19 in our country. Therefore, reference guides on vaccination for clinicians, patients, and public health authorities are particularly important to prevent some infectious diseases. The DCNI/ABN and BCTRIMS recommend that patients with CNS demyelinating diseases (e.g., MS and NMOSD) be continually monitored for updates to their vaccination schedule, especially at the beginning or before a change in treatment with a disease modifying drug (DMD). It is also important to note that vaccines are safe, and physicians should encourage their use in all patients. Clearly, special care should be taken when live attenuated viruses are involved. Finally, it is important for physicians to verify which DMD the patient is receiving and when the last dose was taken, as each drug may affect the induction of immune response differently.pt_BR
dc.format.mimetypepdfpt_BR
dc.languageengpt_BR
dc.publisherUniversidade Federal de Minas Geraispt_BR
dc.publisher.countryBrasilpt_BR
dc.publisher.departmentHCL - HOSPITAL DAS CLINICASpt_BR
dc.publisher.departmentMED - DEPARTAMENTO DE CLÍNICA MÉDICApt_BR
dc.publisher.departmentMED - DEPARTAMENTO DE OFTALMOLOGIA E OTORRINOLARINGOLOGIApt_BR
dc.publisher.initialsUFMGpt_BR
dc.relation.ispartofArquivos de Neuro-Psiquiatriapt_BR
dc.rightsAcesso Abertopt_BR
dc.subjectDemyelinating autoimmune diseases, CNSpt_BR
dc.subjectMultiple sclerosispt_BR
dc.subjectNeuromyelitis opticapt_BR
dc.subjectVaccinationpt_BR
dc.subjectCOVID-19pt_BR
dc.subjectSARS-CoV-2pt_BR
dc.subject.otherCOVID-19 (Doença)pt_BR
dc.subject.otherSARS-CoV-2pt_BR
dc.subject.otherDoenças autoimunes desmielinizantes do sistema nervoso centralpt_BR
dc.subject.otherEsclerose múltiplapt_BR
dc.subject.otherNeuromielite ópticapt_BR
dc.subject.otherVacinaçãopt_BR
dc.titleRecommendations by the Scientific Department of Neuroimmunology of the Brazilian Academy of Neurology (DCNI/ABN) and the Brazilian Committee for Treatment and Research in Multiple Sclerosis and Neuroimmunological Diseases (BCTRIMS) on vaccination in general and specifically against SARS-CoV-2 for patients with demyelinating diseases of the central nervous systempt_BR
dc.title.alternativeRecomendações do Departamento Científico de Neuroimunologia da Academia Brasileira de Neurologia (DCNI/ABN) e do Comitê Brasileiro de Tratamento e Pesquisa em Esclerose Múltipla e Doenças Neuroimunológicas (BCTRIMS) sobre vacinação em geral e contra a SARS-CoV-2 para pacientes com doenças desmielinizantes do sistema nervoso centralpt_BR
dc.typeArtigo de Periódicopt_BR
dc.url.externahttps://www.scielo.br/j/anp/a/H3kbdyFSG783FZmtyjsn3cd/?lang=enpt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-9981-3620pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-4456-2684pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-7919-3989pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-4011-3734pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0003-1224-5243pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0003-0077-173Xpt_BR
dc.identifier.orcidhttps://orcid.org/0000-0003-2454-681Xpt_BR
dc.identifier.orcidhttps://orcid.org/0000-0003-3185-2903pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0001-5690-105Xpt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-5008-2783pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0003-1615-8008pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-5679-1759pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0003-3493-1199pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0003-1657-6891pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-3298-0264pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0003-3548-8467pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-7480-6782pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0003-0834-1056pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-6627-6515pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-0755-9478pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-4084-7973pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0001-7484-3586pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0003-1137-2398pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0003-0833-4024pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-8699-0636pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-3043-1640pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-3078-6804pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-4939-7200pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-8275-3801pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0001-7668-0434pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0003-3242-9007pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-8957-5796pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-8949-6115pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0001-9764-3763pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-2717-7522pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-7333-1420pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0001-5394-648Xpt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-5582-1792pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-1694-0457pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-5758-5789pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-9127-7886pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0001-9393-6999pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0003-3515-4061pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-4402-099Xpt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-5914-8099pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0003-2171-8241pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-6267-2940pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0001-7537-5729pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-9287-6864pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0001-5750-6828pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0003-3987-9596pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-9744-5916pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-8856-0007pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-1538-6730pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-7718-4288pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0001-8202-8856pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0003-1438-2583pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0001-8726-089Xpt_BR
dc.identifier.orcidhttps://orcid.org/0000-0003-3516-485Xpt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-6136-4612pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0003-3983-6019pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-9050-3319pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-1004-7641pt_BR
Appears in Collections:Artigo de Periódico

Files in This Item:
File Description SizeFormat 
Recommendations by the Scientific Department of Neuroimmunology of the Brazilian Academy of Neurology (DCNIABN) and the Brazilian Committee for Treatment and Research in Multiple Sclerosis and Neuroimmunological Diseases.pdf160.31 kBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.